(GALD) Galderma N - Performance 59.7% in 12m
GALD performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
48.76%
#12 in Peer-Group
Rel. Strength
87.64%
#917 in Stock-Universe
Total Return 12m
59.74%
#13 in Peer-Group
Total Return 5y
117.34%
#12 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 139 |
| P/E Forward | 49.5 |
| High / Low | CHF |
|---|---|
| 52 Week High | 119.36 CHF |
| 52 Week Low | 66.01 CHF |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 59.94 |
| Buy/Sell Signal +-5 | -0.61 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: GALD (59.7%) vs XLV (-5.4%)
5y Drawdown (Underwater) Chart
Top Performer in Drug Manufacturers - Specialty & Generic
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| LNTH NASDAQ Lantheus Holdings |
6.13% | 2.32% | 462% | 23 | 11.8 | 0.61 | 60.0% | 46.6% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| SFZN SW Siegfried Holding |
-6.3% | -5% | 110% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| IPN PA Ipsen |
-1.19% | -10.7% | 41.1% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
| SUPN NASDAQ Supernus Pharmaceuticals |
-1.22% | 18.7% | 33.5% | 29.2 | 20.2 | 1.47 | 5.40% | -40.6% |
| PAHC NASDAQ Phibro Animal Health |
4.42% | 53.1% | 12.3% | 31.5 | 10.6 | 1.66 | -37.8% | 4.97% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| TAK NYSE Takeda Pharmaceutical |
2.52% | 21.7% | 5.18% | 65.5 | 14.3 | 0.42 | -14.0% | -0.62% |
Performance Comparison: GALD vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for GALD
| Total Return (including Dividends) | GALD | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 3.88% | 2.04% | 4.55% |
| 3 Months | 23.11% | -7.24% | 10.78% |
| 12 Months | 59.74% | -5.41% | 14.71% |
| 5 Years | 117.34% | 43.58% | 112.53% |
| Trend Score (consistency of price movement) | GALD | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 32.7% | 34.5% | 79.2% |
| 3 Months | 92% | -46.5% | 92.9% |
| 12 Months | 75.6% | -71.8% | 44.2% |
| 5 Years | 86.4% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th66.67 | 1.80% | -0.64% |
| 3 Month | %th81.56 | 32.72% | 11.13% |
| 12 Month | %th90.78 | 68.89% | 39.26% |
| 5 Years | %th94.33 | 130.01% | 80.85% |
FAQs
Does Galderma N (GALD) outperform the market?
Yes,
over the last 12 months GALD made 59.74%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.41%.
Over the last 3 months GALD made 23.11%, while XLV made -7.24%.
Performance Comparison GALD vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
GALD vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.4% | -0.7% | 6.9% | 45% |
| US NASDAQ 100 | QQQ | -0.4% | -1.7% | 4.7% | 45% |
| German DAX 40 | DAX | 0.5% | 3.9% | -6.1% | 30% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.7% | -0.3% | 8.9% | 42% |
| Hongkong Hang Seng | HSI | 0.8% | -1.9% | -8.9% | 24% |
| India NIFTY 50 | INDA | 0.8% | 1.8% | 7.2% | 60% |
| Brasil Bovespa | EWZ | -1% | -3.9% | -17.6% | 46% |
GALD vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.2% | -2.9% | 0.2% | 31% |
| Consumer Discretionary | XLY | 2% | 2.3% | 15.6% | 40% |
| Consumer Staples | XLP | 3.9% | 5.5% | 8.7% | 51% |
| Energy | XLE | 4.7% | 0.4% | 12.3% | 64% |
| Financial | XLF | 0.3% | 0.8% | 3.8% | 31% |
| Health Care | XLV | 1.3% | 1.8% | 14.1% | 65% |
| Industrial | XLI | 0.8% | 0.1% | 0.3% | 36% |
| Materials | XLB | 2.3% | 2.3% | 7.5% | 57% |
| Real Estate | XLRE | 4.8% | 3.9% | 9.5% | 47% |
| Technology | XLK | -0.9% | -5% | 3.7% | 48% |
| Utilities | XLU | 2.8% | 3.8% | 3.5% | 36% |
| Aerospace & Defense | XAR | -1.6% | -6% | -14.5% | 7% |
| Biotech | XBI | 2.5% | 1.8% | 20.8% | 71% |
| Homebuilder | XHB | 2.1% | -2.2% | 18.2% | 59% |
| Retail | XRT | 3.5% | 2.5% | 15.6% | 54% |
GALD vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 7.6% | -1.24% | 16.2% | 70% |
| Natural Gas | UNG | 12.6% | 13.3% | 22% | 68% |
| Gold | GLD | 5.3% | 6.1% | -13% | 18% |
| Silver | SLV | 3.8% | 0% | -11.7% | 38% |
| Copper | CPER | 0.1% | -0.3% | -12.8% | 45% |
GALD vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.6% | 0.3% | 10.1% | 58% |
| iShares High Yield Corp. Bond | HYG | 2.4% | 2% | 7.9% | 49% |